Form 8-K - Current report:
SEC Accession No. 0001140361-22-037727
Filing Date
2022-10-19
Accepted
2022-10-19 06:13:14
Documents
12
Period of Report
2022-10-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ny20005570x2_8k.htm   iXBRL 8-K 46566
  Complete submission text file 0001140361-22-037727.txt   187906

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA insm-20221019.xsd EX-101.SCH 3860
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE insm-20221019_lab.xml EX-101.LAB 22547
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE insm-20221019_pre.xml EX-101.PRE 16041
6 EXTRACTED XBRL INSTANCE DOCUMENT ny20005570x2_8k_htm.xml XML 4065
Mailing Address 700 US HIGHWAY 202/206 BRIDGEWATER NJ 08807
Business Address 700 US HIGHWAY 202/206 BRIDGEWATER NJ 08807 908-977-9900
INSMED Inc (Filer) CIK: 0001104506 (see all company filings)

EIN.: 541972729 | State of Incorp.: VA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30739 | Film No.: 221317183
SIC: 2834 Pharmaceutical Preparations